Abstract
Tax protein of human T-cell leukemia virus type 1 (HTLV-1) is a potent transcriptional regulator which can activate or repress specific cellular genes and has been proposed to contribute to leukemogenic processes in adult T-cell leukemia. The molecular mechanism of Tax-mediated trans-activation has been well investigated. However, trans-repression by Tax remains to be studied in detail, although it is known to require a specific DNA element such as E-box or p53 binding site. Examining possible mechanisms of trans-repression, we found that co-expression of E47 and p300 activated E-box dependent transcription and this activation was efficiently repressed by Tax. In this system, Tax bound to p300 and decreased the level of p300 complexed on the E-box element. Similarly, Tax inhibited transcription directed by p53 and CBP, reducing the level of CBP on the p53 binding site. These results indicate that Tax interferes with recruitment of CBP/p300 into protein complexes on E-box and p53 binding site through its binding to CBP/p300. In contrast to these findings, we observed that Tax increased the level of CBP on the viral 21-bp enhancer which is trans-activated by Tax. From these observations, we propose a universal mechanism for Tax-mediated trans-repression and trans-activation of transcription in which Tax binds to CBP/p300 and determines the accessibility of CBP/p300 to protein complexes on specific DNA element.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akagi T, Ono H, Tsuchida N and Shimotohno K. . 1997 FEBS Lett. 406: 263–266.
Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS and Kelly K. . 1997 Cell 89: 1175–1184.
Bannister AJ and Kouzarides T. . 1996 Nature 384: 641–643.
Bex F, Yin M-J, Burny A and Gaynor RB. . 1998 Mol. Cell. Biol. 18: 2392–2405.
Borrow J, Stanton VP, Andresen M, Becher R, Behm FG, Chaganti RSK, Civin CI, Disteche C, Dube I, Frischauf AM, Horsman D, Mitelman F, Volinia S, Watmore AE and Housman DE. . 1996 Nat. Genet. 14: 33–41.
Brauweiler A, Garrus JE, Reed JC and Nyborg JK. . 1997 Virology 231: 135–140.
Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR and Goodman RH. . 1993 Nature 365: 855–859.
Colgin MA and Nybork JK. . 1998 J. Virol. 72: 9396–9399.
Eckner R, Yao T-P, Oldread E and Livingston DM. . 1996 Gene Dev. 10: 2478–2490.
Fujii M, Tsuchiya H, Chuhjo T, Akizawa T and Seiki M. . 1992 Genes Dev. 6: 2066–2076.
Giebler HA, Loring JE, Van Orden K, Colgin MA, Garrus JE, Escudero KE, Brauweiler A and Nyborg JK. . 1997 Mol. Cell. Biol. 17: 5156–5164.
Giles RH, Peters DJM and Breuning MH. . 1998 Trends Genet. 14: 178–183.
Grassmann R, Dengler C, Muller-Fleckenstein I, Fleckenstein M, McGuire K, Dokhelar MC, Sodroski JC and Haseltine WA. . 1989 Proc. Natl. Acad. Sci. USA 86: 3351–3355.
Grossman WJ, Kimata JT, Wong FH, Zutter M, Ley TJ and Ratner L. . 1995 Proc. Natl. Acad. Sci. USA 92: 1057–1061.
Gu W, Shi X-L and Roeder RG. . 1997 Nature 387: 819–823.
Harrod R, Tang Y, Nicot C, Lu HS, Vassilev A, Nakatani Y and Giam C-Z. . 1998 Mol. Cell. Biol. 18: 5052–5061.
Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, Shirakawa S and Miyoshi I. . 1981 Proc. Natl. Acad. Sci. USA 78: 6476–6480.
Ida K, Kitabayashi I, Taki T, Taniwaki M, Noro K, Yamamoto M, Ohki M and Hayashi Y. . 1997 Blood 90: 4699–4704.
Jeang KT, Widen SG, Semmes OJ and Wison SH. . 1990 Science 247: 1082–1084.
Kwok RPS, Laurance ME, Lundblad JR, Goldman PS, Shih H-S, Connor LM, Marriott SJ and Goodman RH. . 1996 Nature 380: 642–646.
Lemasson I, Robert-Hebmann V, Hamaia S, Duc Doden M, Gazzolo L and Devaux C. . 1997 J. Virol. 71: 1975–1983.
Lenzmeier BA, Giebler HA and Nyborg JK. . 1998 Mol. Cell. Biol. 18: 721–731.
Lill NL, Grossmann SR, Ginsberg D, DeCaprio J and Livingston DM. . 1997 Nature 387: 823–827.
Mulloy JC, Kislyakova T, Cereseto A, Casareto L, LoMonico A, Fullen J, Lorenzi MV, Cara A, Nicot C, Giam C and Franchini G. . 1998 J. Virol. 72: 8852–8860.
Muraoka M, Konishi M, Kikuchi-Yanoshita R, Tanaka K, Shitara N, Chong JM, Iwama T and Miyaki M. . 1996 Oncogene 12: 1565–1569.
Ogryzko VV, Schiltz RL, Russanova V, Howard BH and Nakatani Y. . 1996 Cell 87: 953–959.
Petrij F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RCM, Masuno M, Tommerup N, van Ommen G-JB, Goodman RH, Peters DJM and Breuning MH. . 1995 Nature 376: 348–351.
Pise-Masison CA, Choi K-S, Radonovich M, Dittmer J, Kim S-J and Brady JN. . 1998a J. Virol. 72: 1165–1170.
Pise-Masison CA, Radonovich M, Sakaguchi K, Appella E and Brady JN. . 1998b J. Virol. 72: 6348–6355.
Poeisz BJ, Ruscetti RW, Gazdar AF, Bunn PA, Minna JD and Gallo RC. . 1980 Proc. Natl. Acad. Sci. USA 77: 7415–7419.
Shikama N, Lyon J and La Thangue NB. . 1997 Trends Cell Biol. 7: 230–236.
Sobulo OM, Borrow J, Tomek R, Reshmi S, Harden A, Schlegelberger B, Housman D, Doggett NA, Rowley JD and Zeleznik-Le NJ. . 1997 Proc. Natl. Acad. Sci. USA 94: 8732–8737.
Suzuki T, Fujisawa J, Toita M and Yoshida M. . 1993 Proc. Natl. Acad. Sci. USA 90: 610–614.
Suzuki T, Hirai H and Yoshida M. . 1994 Oncogene 9: 3099–3105.
Suzuki T, Kitao S, Matsushime H and Yoshida M. . 1996 EMBO J. 15: 1607–1614.
Uittenbogaard MN, Armstrong AP, Chiaramello A and Nyborg JK. . 1994 J. Biol. Chem. 269: 22466–22469.
Yamaoka S, Inoue H, Sakurai M, Sugiyama T, Hazama M, Yamada T and Hatanaka M. . 1996 EMBO J. 15: 873–887.
Yang XJ, Ogryzko VV, Nishikawa J, Howard BH and Nakatani Y. . 1996 Nature 382: 319–324.
Yoshida M. . 1993 Trends Microbiol. 1: 131–135.
Yoshida M, Miyoshi I and Hinuma Y. . 1982 Proc. Natl. Acad. Sci. USA 79: 2031–2035.
Yoshida M, Suzuki T, Fujisawa J and Hirai H. . 1995 Curr. Top. Microbiol. Immunol. 193: 79–89.
Zhao LJ and Giam CZ. . 1992 Proc. Natl. Acad. Sci. USA 89: 7070–7074.
Acknowledgements
We thank Dr K Umesono, Kyoto University, Dr S Ishii, Tsukuba Life Science Center, RIKEN, and Dr K Semba, University of Tokyo for providing cDNAs and expression plasmids. This work was supported in part by a special grant for Advanced Research on Cancer from the Ministry of Education, Culture, Sports and Science of Japan.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Suzuki, T., Uchida-Toita, M. & Yoshida, M. Tax protein of HTLV-1 inhibits CBP/p300-mediated transcription by interfering with recruitment of CBP/p300 onto DNA element of E-box or p53 binding site. Oncogene 18, 4137–4143 (1999). https://doi.org/10.1038/sj.onc.1202766
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202766
Keywords
This article is cited by
-
KATs in cancer: functions and therapies
Oncogene (2015)
-
ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells
Retrovirology (2011)
-
Induction of p21CIP1/WAF1expression by human T-lymphotropic virus type 1 Tax requires transcriptional activation and mRNA stabilization
Retrovirology (2009)
-
Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)
Retrovirology (2005)
-
Activation of NF-κB by HTLV-I and implications for cell transformation
Oncogene (2005)